DACH venture capital looks for a new normal
Although dealflow in the DACH VC market has remained fairly strong amid the coronavirus crisis, deals have shrunk in average size, and uncertainty lingers. Harriet Matthews reports
More on Venture
Biotech market provides dose of optimism
In the past year, the biotech market has seen buoyant activity, reaching record levels of investments
How European venture capital weathered a rocky 2020
Q2 reflected a nice uptick in investment activity, and aggregate value continued climbing as the year went on
Unquote Private Equity Podcast: Venture's immunity
Simon Philips, CEO of ScaleUp Capital, joins the Unquote podcast to explore recent trends in the European venture space
Ion Pacific nears first close for VC secondaries fund
Hong Kong-based manager is expecting commitments of roughly $40m at first close for the global fund
Latest News
Pride Capital sells stake in Kairos to trade
Direct lender invested in Kairos in 2018 and was part of Main Capital until its spin-out in 2019
One Equity Partners buys stake in Cicor Group
GP is to acquire a stake in the Switzerland-based circuit board producer from HEB Swiss Investment
Alantra buys 40% stake in MCH Investment Strategies
Through this partnership, Alantra expects to expand its financial service offering and enlarge its investor base
KKR invests $100m in Nordic Bioscience
GP is investing from Health Care Strategic Growth Fund, which held a final close in November 2017 on $1.2bn